Skip to main content
Erschienen in: American Journal of Cardiovascular Drugs 5/2022

01.09.2022 | Systematic Review

The Effect of Vasopressin and Methylprednisolone on Return of Spontaneous Circulation in Patients with In-Hospital Cardiac Arrest: A Systematic Review and Meta-analysis of Randomized Controlled Trials

verfasst von: Basel Abdelazeem, Ahmed K. Awad, Nouraldeen Manasrah, Merihan A. Elbadawy, Soban Ahmad, Pramod Savarapu, Kirellos Said Abbas, Arvind Kunadi

Erschienen in: American Journal of Cardiovascular Drugs | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Cardiac arrest is often fatal if not treated immediately by cardiopulmonary resuscitation to restore a normal heart rhythm and spontaneous circulation. We aim to evaluate the clinical benefits of vasopressin and methylprednisolone versus placebo for patients with in-hospital cardiac arrest.

Data Sources

We searched PubMed, EMBASE, Scopus, Web of Science, Cochrane Central, and Google Scholar from inception to October 17, 2021, by using search terms included "Vasopressin" AND "Methylprednisolone" AND "Cardiac arrest".

Study Selection and Data Extraction

We included randomized controlled trials (RCTs) that compared vasopressin and methylprednisolone to placebo. The main outcomes were the return of spontaneous circulation (ROSC) and survival to hospital discharge.

Data Synthesis

A total of three RCTs, with a total of 869 patients, were included. The pooled risk ratios (RRs) were calculated along with their 95% confidence intervals (CIs). Our result showed an increase in ROSC in patients who received vasopressin and methylprednisolone (RR = 1.32; 95% CI = [1.18, 1.47], p < 0.00001) when compared with the placebo group. However, there was no difference between both groups regarding survival to hospital discharge (RR = 1.76; 95% CI = [0.68, 4.56], p= 0.25).

Relevance to Patient Care and Clinical Practice

The current guidelines recommend epinephrine for patients with in-hospital cardiac arrest. Our meta-analysis updates clinicians about using vasopressin and methylprednisolone besides epinephrine, providing them with the best available evidence in managing patients with in-hospital cardiac arrest.

Conclusion

Among patients with in-hospital cardiac arrest, administration of vasopressin and methylprednisolone besides epinephrine is associated with increased ROSC compared with placebo and epinephrine. However, high-quality RCTs are necessary before drawing a firm conclusion regarding the efficacy of vasopressin and methylprednisolone for patients with in-hospital cardiac arrest.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sandroni C, Nolan J, Cavallaro F, Antonelli M. In-hospital cardiac arrest: incidence, prognosis and possible measures to improve survival. Intensive Care Med. 2006;33(2):237–45.CrossRef Sandroni C, Nolan J, Cavallaro F, Antonelli M. In-hospital cardiac arrest: incidence, prognosis and possible measures to improve survival. Intensive Care Med. 2006;33(2):237–45.CrossRef
2.
Zurück zum Zitat Andersen LW, Holmberg MJ, Berg KM, Donnino MW, Granfeldt A. In-hospital cardiac arrest: a review. JAMA. 2019;321(12):1200–10.CrossRef Andersen LW, Holmberg MJ, Berg KM, Donnino MW, Granfeldt A. In-hospital cardiac arrest: a review. JAMA. 2019;321(12):1200–10.CrossRef
3.
Zurück zum Zitat Girotra S, Nallamothu BK, Spertus JA, Li Y, Krumholz HM, Chan PS, et al. Trends in survival after in-hospital cardiac arrest. N Engl J Med. 2012;367(20):1912–20.CrossRef Girotra S, Nallamothu BK, Spertus JA, Li Y, Krumholz HM, Chan PS, et al. Trends in survival after in-hospital cardiac arrest. N Engl J Med. 2012;367(20):1912–20.CrossRef
4.
Zurück zum Zitat Olasveengen TM, Semeraro F, Ristagno G, Castren M, Handley A, Kuzovlev A, et al. European resuscitation council guidelines 2021: basic life support. Resuscitation. 2021;161:98–114.CrossRef Olasveengen TM, Semeraro F, Ristagno G, Castren M, Handley A, Kuzovlev A, et al. European resuscitation council guidelines 2021: basic life support. Resuscitation. 2021;161:98–114.CrossRef
5.
Zurück zum Zitat Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, et al. Part 8: adult advanced cardiovascular life support. Circulation. 2010;122(18_suppl_3):S729–67CrossRef Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, et al. Part 8: adult advanced cardiovascular life support. Circulation. 2010;122(18_suppl_3):S729–67CrossRef
6.
Zurück zum Zitat Krismer AC, Dnser MW, Lindner KH, Stadlbauer KH, Mayr VD, Lienhart HG, et al. Vasopressin during cardiopulmonary resuscitation and different shock states. Am J Cardiovasc Drugs. 2006;6(1):51–68.CrossRef Krismer AC, Dnser MW, Lindner KH, Stadlbauer KH, Mayr VD, Lienhart HG, et al. Vasopressin during cardiopulmonary resuscitation and different shock states. Am J Cardiovasc Drugs. 2006;6(1):51–68.CrossRef
7.
Zurück zum Zitat Hékimian G, Baugnon T, Thuong M, Monchi M, Dabbane H, Jaby DL, et al. Cortisol levels and adrenal reserve after successful cardiac arrest resuscitation. Shock. 2004;22(2):116–9.CrossRef Hékimian G, Baugnon T, Thuong M, Monchi M, Dabbane H, Jaby DL, et al. Cortisol levels and adrenal reserve after successful cardiac arrest resuscitation. Shock. 2004;22(2):116–9.CrossRef
8.
Zurück zum Zitat Ito T, Saitoh D, Takasu A, Kiyozumi T, Sakamoto T, Okada Y. Serum cortisol as a predictive marker of the outcome in patients resuscitated after cardiopulmonary arrest. Resuscitation. 2004;62(1):55–60.CrossRef Ito T, Saitoh D, Takasu A, Kiyozumi T, Sakamoto T, Okada Y. Serum cortisol as a predictive marker of the outcome in patients resuscitated after cardiopulmonary arrest. Resuscitation. 2004;62(1):55–60.CrossRef
9.
Zurück zum Zitat Sahebnasagh A, Nejad PS, Salehi-Abargouei A, Dehghani MH, Saghafi F. A characterization of cortisol level and adrenal reservation in human cardiopulmonary arrest: systematic review and meta-analysis. Syst Rev. 2021;10(1):266.CrossRef Sahebnasagh A, Nejad PS, Salehi-Abargouei A, Dehghani MH, Saghafi F. A characterization of cortisol level and adrenal reservation in human cardiopulmonary arrest: systematic review and meta-analysis. Syst Rev. 2021;10(1):266.CrossRef
10.
Zurück zum Zitat Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.CrossRef Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.CrossRef
11.
Zurück zum Zitat Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.CrossRef Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.CrossRef
13.
Zurück zum Zitat Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.CrossRef Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.CrossRef
14.
Zurück zum Zitat Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
15.
Zurück zum Zitat Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.CrossRef Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.CrossRef
16.
Zurück zum Zitat Axtell AL, Funamoto M, Legassey AG, Moonsamy P, Shelton K, D’Alessandro DA, et al. Predictors of neurologic recovery in patients who undergo extracorporeal membrane oxygenation for refractory cardiac arrest. J Cardiothorac Vasc Anesth. 2020;34(2):356–62.CrossRef Axtell AL, Funamoto M, Legassey AG, Moonsamy P, Shelton K, D’Alessandro DA, et al. Predictors of neurologic recovery in patients who undergo extracorporeal membrane oxygenation for refractory cardiac arrest. J Cardiothorac Vasc Anesth. 2020;34(2):356–62.CrossRef
17.
Zurück zum Zitat Mentzelopoulos SD, Koliantzaki I, Karvouniaris M, Vrettou C, Mongardon N, Karlis G, et al. Publisher correction: exposure to stress-dose steroids and lethal septic shock after in-hospital cardiac arrest: individual patient data reanalysis of two prior randomized clinical trials that evaluated the vasopressin-steroids-epinephrine combination versus epinephrine alone. Cardiovasc Drugs Ther. 2018;32(6):639–41.CrossRef Mentzelopoulos SD, Koliantzaki I, Karvouniaris M, Vrettou C, Mongardon N, Karlis G, et al. Publisher correction: exposure to stress-dose steroids and lethal septic shock after in-hospital cardiac arrest: individual patient data reanalysis of two prior randomized clinical trials that evaluated the vasopressin-steroids-epinephrine combination versus epinephrine alone. Cardiovasc Drugs Ther. 2018;32(6):639–41.CrossRef
18.
Zurück zum Zitat Papastylianou AMS, Zakynthinos S, Zakynthinos E, Makris D, Sourlas S, Aloizos S, Mentzelopoulos S. Predictors of neurological recovery in refractory in hospital cardiac arrest. ESICM 2010 MONDAY SESSIONS 11 October 2010. Intensive Care Med. 2010;36:86–204.CrossRef Papastylianou AMS, Zakynthinos S, Zakynthinos E, Makris D, Sourlas S, Aloizos S, Mentzelopoulos S. Predictors of neurological recovery in refractory in hospital cardiac arrest. ESICM 2010 MONDAY SESSIONS 11 October 2010. Intensive Care Med. 2010;36:86–204.CrossRef
19.
Zurück zum Zitat Mentzelopoulos SD, Malachias S, Chamos C, Konstantopoulos D, Ntaidou T, Papastylianou A, et al. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial. JAMA. 2013;310(3):270–9.CrossRef Mentzelopoulos SD, Malachias S, Chamos C, Konstantopoulos D, Ntaidou T, Papastylianou A, et al. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial. JAMA. 2013;310(3):270–9.CrossRef
20.
Zurück zum Zitat Ballew KA, ACP Journal Club. Combined vasopressin, steroids, and epinephrine improved survival in in-hospital cardiac arrest. Ann Intern Med. 2013;159(10):JC4.CrossRef Ballew KA, ACP Journal Club. Combined vasopressin, steroids, and epinephrine improved survival in in-hospital cardiac arrest. Ann Intern Med. 2013;159(10):JC4.CrossRef
21.
Zurück zum Zitat Haukoos J, Douglas IS, Sasson C. Vasopressin and steroids as adjunctive treatment for in-hospital cardiac arrest. JAMA. 2021;326(16):1583–5.CrossRef Haukoos J, Douglas IS, Sasson C. Vasopressin and steroids as adjunctive treatment for in-hospital cardiac arrest. JAMA. 2021;326(16):1583–5.CrossRef
22.
Zurück zum Zitat Rehnberg JV, Patrick N. Vasopressin, steroids and epinephrine and neurologically favourable survival after in-hospital cardiac arrest. J Intensive Care Soc. 2015;16(1):77–9.CrossRef Rehnberg JV, Patrick N. Vasopressin, steroids and epinephrine and neurologically favourable survival after in-hospital cardiac arrest. J Intensive Care Soc. 2015;16(1):77–9.CrossRef
23.
Zurück zum Zitat Berg RA, Meaney PA, Nadkarni VM. Does a resuscitation pharmacologic bundle of epinephrine, terlipressin, and corticosteroids improve outcome from asphyxial cardiac arrest? Pediatr Crit Care Med. 2014;15(6):573–4.CrossRef Berg RA, Meaney PA, Nadkarni VM. Does a resuscitation pharmacologic bundle of epinephrine, terlipressin, and corticosteroids improve outcome from asphyxial cardiac arrest? Pediatr Crit Care Med. 2014;15(6):573–4.CrossRef
24.
Zurück zum Zitat Andersen LW, Sindberg B, Holmberg M, Isbye D, Kjaergaard J, Zwisler ST, et al. Vasopressin and methylprednisolone for in-hospital cardiac arrest—protocol for a randomized, double-blind, placebo-controlled trial. Resusc Plus. 2021;5:100081.CrossRef Andersen LW, Sindberg B, Holmberg M, Isbye D, Kjaergaard J, Zwisler ST, et al. Vasopressin and methylprednisolone for in-hospital cardiac arrest—protocol for a randomized, double-blind, placebo-controlled trial. Resusc Plus. 2021;5:100081.CrossRef
25.
Zurück zum Zitat Andersen LW, Isbye D, Kjaergaard J, Kristensen CM, Darling S, Zwisler ST, et al. Effect of vasopressin and methylprednisolone vs placebo on return of spontaneous circulation in patients with in-hospital cardiac arrest: a randomized clinical trial. JAMA. 2021;326:1586–94.CrossRef Andersen LW, Isbye D, Kjaergaard J, Kristensen CM, Darling S, Zwisler ST, et al. Effect of vasopressin and methylprednisolone vs placebo on return of spontaneous circulation in patients with in-hospital cardiac arrest: a randomized clinical trial. JAMA. 2021;326:1586–94.CrossRef
26.
Zurück zum Zitat Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, Katsios N, Papastylianou A, Gkisioti S, et al. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med. 2009;169(1):15–24.CrossRef Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, Katsios N, Papastylianou A, Gkisioti S, et al. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med. 2009;169(1):15–24.CrossRef
27.
Zurück zum Zitat Reynolds JC, Salcido DD, Menegazzi JJ. Coronary perfusion pressure and return of spontaneous circulation after prolonged cardiac arrest. Prehosp Emerg Care. 2010;14(1):78–84.CrossRef Reynolds JC, Salcido DD, Menegazzi JJ. Coronary perfusion pressure and return of spontaneous circulation after prolonged cardiac arrest. Prehosp Emerg Care. 2010;14(1):78–84.CrossRef
28.
Zurück zum Zitat Paradis NA. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. J Am Med Assoc. 1990;263(8):1106.CrossRef Paradis NA. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. J Am Med Assoc. 1990;263(8):1106.CrossRef
29.
Zurück zum Zitat Leopold V, Gayat E, Pirracchio R, Spinar J, Parenica J, Tarvasmaki T, et al. Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients. Intensive Care Med. 2018;44(6):847–56.CrossRef Leopold V, Gayat E, Pirracchio R, Spinar J, Parenica J, Tarvasmaki T, et al. Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients. Intensive Care Med. 2018;44(6):847–56.CrossRef
30.
Zurück zum Zitat Angelos MG, Butke RL, Panchal AR, Torres CAA, Blumberg A, Schneider JE, et al. Cardiovascular response to epinephrine varies with increasing duration of cardiac arrest. Resuscitation. 2008;77(1):101–10.CrossRef Angelos MG, Butke RL, Panchal AR, Torres CAA, Blumberg A, Schneider JE, et al. Cardiovascular response to epinephrine varies with increasing duration of cardiac arrest. Resuscitation. 2008;77(1):101–10.CrossRef
31.
Zurück zum Zitat Stroumpoulis K, Xanthos T, Rokas G, Kitsou V, Papadimitriou D, Serpetinis I, et al. Vasopressin and epinephrine in the treatment of cardiac arrest: an experimental study. Crit Care. 2008;12(2):R40.CrossRef Stroumpoulis K, Xanthos T, Rokas G, Kitsou V, Papadimitriou D, Serpetinis I, et al. Vasopressin and epinephrine in the treatment of cardiac arrest: an experimental study. Crit Care. 2008;12(2):R40.CrossRef
32.
Zurück zum Zitat Gk Mutlu, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med. 2004;30(7):1276–91. Gk Mutlu, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med. 2004;30(7):1276–91.
33.
Zurück zum Zitat Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg. 2008;107(2):620–4.CrossRef Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg. 2008;107(2):620–4.CrossRef
34.
Zurück zum Zitat Sreevastava DK, Roy PK, Dass SK, Bhargava A, Chakrabarty A, Rai V, et al. Cardio-pulmonary resuscitation: an overview of recent advances in concepts and practices. Med J Armed Forces India. 2004;60(1):52–8.CrossRef Sreevastava DK, Roy PK, Dass SK, Bhargava A, Chakrabarty A, Rai V, et al. Cardio-pulmonary resuscitation: an overview of recent advances in concepts and practices. Med J Armed Forces India. 2004;60(1):52–8.CrossRef
35.
Zurück zum Zitat Stiell IG, Hébert PC, Wells GA, Vandemheen KL, Tang ASL, Higginson LAJ, et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet. 2001;358(9276):105–9.CrossRef Stiell IG, Hébert PC, Wells GA, Vandemheen KL, Tang ASL, Higginson LAJ, et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet. 2001;358(9276):105–9.CrossRef
36.
Zurück zum Zitat Tsai M-S, Huang C-H, Chang W-T, Chen W-J, Hsu C-Y, Hsieh C-C, et al. The effect of hydrocortisone on the outcome of out-of-hospital cardiac arrest patients: a pilot study. Am J Emerg Med. 2007;25(3):318–25.CrossRef Tsai M-S, Huang C-H, Chang W-T, Chen W-J, Hsu C-Y, Hsieh C-C, et al. The effect of hydrocortisone on the outcome of out-of-hospital cardiac arrest patients: a pilot study. Am J Emerg Med. 2007;25(3):318–25.CrossRef
37.
Zurück zum Zitat Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004;350(2):105–13.CrossRef Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004;350(2):105–13.CrossRef
38.
Zurück zum Zitat Soar J, Bottiger BW, Carli P, Couper K, Deakin CD, Djarv T, et al. European Resuscitation Council Guidelines 2021: adult advanced life support. Resuscitation. 2021;161:115–51.CrossRef Soar J, Bottiger BW, Carli P, Couper K, Deakin CD, Djarv T, et al. European Resuscitation Council Guidelines 2021: adult advanced life support. Resuscitation. 2021;161:115–51.CrossRef
39.
Zurück zum Zitat Belletti A, Benedetto U, Putzu A, Martino EA, Biondi-Zoccai G, Angelini GD, et al. Vasopressors during cardiopulmonary resuscitation. A network meta-analysis of randomized trials. Crit Care Med. 2018;46(5):e443–51.CrossRef Belletti A, Benedetto U, Putzu A, Martino EA, Biondi-Zoccai G, Angelini GD, et al. Vasopressors during cardiopulmonary resuscitation. A network meta-analysis of randomized trials. Crit Care Med. 2018;46(5):e443–51.CrossRef
40.
Zurück zum Zitat Shah K, Mitra AR. Use of corticosteroids in cardiac arrest-a systematic review and meta-analysis. Crit Care Med. 2021;49(6):e642–50.CrossRef Shah K, Mitra AR. Use of corticosteroids in cardiac arrest-a systematic review and meta-analysis. Crit Care Med. 2021;49(6):e642–50.CrossRef
41.
Zurück zum Zitat Shah K, Mitra AR. The authors reply. Crit Care Med. 2021;49(12):e1259–60.CrossRef Shah K, Mitra AR. The authors reply. Crit Care Med. 2021;49(12):e1259–60.CrossRef
42.
Zurück zum Zitat Hoybye M, Stankovic N, Holmberg M, Christensen HC, Granfeldt A, Andersen LW. In-hospital vs. out-of-hospital cardiac arrest: patient characteristics and survival. Resuscitation. 2021;158:157–65.CrossRef Hoybye M, Stankovic N, Holmberg M, Christensen HC, Granfeldt A, Andersen LW. In-hospital vs. out-of-hospital cardiac arrest: patient characteristics and survival. Resuscitation. 2021;158:157–65.CrossRef
Metadaten
Titel
The Effect of Vasopressin and Methylprednisolone on Return of Spontaneous Circulation in Patients with In-Hospital Cardiac Arrest: A Systematic Review and Meta-analysis of Randomized Controlled Trials
verfasst von
Basel Abdelazeem
Ahmed K. Awad
Nouraldeen Manasrah
Merihan A. Elbadawy
Soban Ahmad
Pramod Savarapu
Kirellos Said Abbas
Arvind Kunadi
Publikationsdatum
01.09.2022
Verlag
Springer International Publishing
Erschienen in
American Journal of Cardiovascular Drugs / Ausgabe 5/2022
Print ISSN: 1175-3277
Elektronische ISSN: 1179-187X
DOI
https://doi.org/10.1007/s40256-022-00522-z

Weitere Artikel der Ausgabe 5/2022

American Journal of Cardiovascular Drugs 5/2022 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.